Related Experiment Video
Updated: Jul 8, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Spliceosomal protein E regulates neoplastic cell growth by modulating expression of cyclin E/CDK2 and G2/M checkpoint
1Department of Vectorology & Experimental Gene Therapy, Biomedical Research Center, University of Rostock, Germany.
Abstract:
Small nuclear ribonucleoproteins are essential splicing factors. We previously identified the spliceosomal protein E (SmE) as a downstream effector of E2F1 in p53-deficient human carcinoma cells. Here, we investigated the biological relevance of SmE in determining the fate of cancer and non-tumourigenic cells. Adenovirus-mediated expression of SmE selectively reduces growth of cancerous cells due to decreased cell proliferation but not apoptosis. A similar growth inhibitory effect for SmD1 suggests that this is a general function of Sm-family members. Deletion of Sm-motifs reveals the importance of the Sm-1 domain for growth suppression. Consistently, SmE overexpression leads to inhibition of DNA synthesis and G2 arrest as shown by BrdU-incorporation and MPM2-staining. Real-time RT-PCR and immunoblotting showed that growth arrest by SmE directly correlates with the reduction of cyclin E, CDK2, CDC25C and CDC2 expression, and up-regulation of p27Kip. Importantly, SmE activity was not associated with enhanced expression of other spliceosome components such as U1 SnRNP70, suggesting that the growth inhibitory effect of SmE is distinct from its pre-mRNA splicing function. Furthermore, specific inactivation of SmE by shRNA significantly increased the percentage of cells in S phase, whereas the amount of G2/M arrested cells was reduced. Our data provide evidence that Sm proteins function as suppressors of tumour cell growth and may have major implications as cancer therapeutics.
Insights
Small nuclear ribonucleoproteins (Sm proteins) like SmE suppress tumor cell growth by inhibiting proliferation and DNA synthesis. This finding suggests Sm proteins may be potential cancer therapeutics.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Small nuclear ribonucleoproteins (Sm proteins) are crucial for pre-mRNA splicing.
- The spliceosomal protein E (SmE) was previously identified as an E2F1 effector in p53-deficient human carcinoma cells.
Purpose of the Study:
- To investigate the biological role of SmE in cancer and non-tumourigenic cells.
- To determine if Sm proteins function as tumor suppressors.
Main Methods:
- Adenovirus-mediated SmE expression in cancer cells.
- Analysis of cell proliferation, apoptosis, DNA synthesis (BrdU incorporation), and cell cycle progression (MPM2 staining).
- Real-time RT-PCR and immunoblotting to assess gene and protein expression.
- SmE inactivation using short hairpin RNA (shRNA).
Main Results:
- SmE expression selectively inhibited cancerous cell growth by reducing proliferation, not inducing apoptosis.
- SmE overexpression caused DNA synthesis inhibition and G2 arrest, correlating with altered expression of cyclins, CDKs, and p27Kip.
- SmE activity was independent of other spliceosome components, suggesting a distinct function.
- SmE inactivation by shRNA led to increased S phase cells and reduced G2/M arrest.
Conclusions:
- Sm proteins, including SmE, act as suppressors of tumor cell growth.
- The growth-inhibitory function of SmE is linked to cell cycle regulation, not its splicing activity.
- Sm proteins hold significant potential as novel cancer therapeutics.
More Related Videos
10:54Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
Related Concept Videos
Negative Regulator Molecules
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System